Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
0.9523
+0.0024 (0.25%)
May 15, 2026, 4:00 PM EDT - Market closed

ZYBT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4555----
Market Cap Growth
-90.87%-----
Enterprise Value
48.4565.860000
Last Close Price
0.951.15----
PE Ratio
--5.48----
PS Ratio
2.713.28----
PB Ratio
1.261.53----
P/TBV Ratio
0.180.22----
P/FCF Ratio
24.9430.95----
P/OCF Ratio
23.6828.61----
EV/Sales Ratio
2.913.96----
EV/EBITDA Ratio
--10.33----
EV/EBIT Ratio
--6.53----
EV/FCF Ratio
26.7737.38----
Debt / Equity Ratio
0.240.240.220.260.180.09
Debt / EBITDA Ratio
-1.68-1.682.131.300.770.44
Debt / FCF Ratio
6.096.093.152.20-6.492.35
Net Debt / Equity Ratio
0.090.090.230.270.190.09
Net Debt / EBITDA Ratio
-0.52-0.521.641.070.650.35
Net Debt / FCF Ratio
1.881.882.421.80-5.521.86
Asset Turnover
0.250.250.380.420.540.48
Inventory Turnover
1.901.901.631.662.272.03
Quick Ratio
0.580.580.780.770.950.86
Current Ratio
1.141.141.311.261.411.31
Return on Equity (ROE)
-25.17%-25.17%3.89%10.78%16.50%14.57%
Return on Assets (ROA)
-16.38%-17.51%3.10%7.56%11.90%10.30%
Return on Invested Capital (ROIC)
-20.00%-21.37%3.58%8.94%14.62%12.81%
Return on Capital Employed (ROCE)
-20.94%-20.94%4.65%12.55%19.16%16.39%
Earnings Yield
-22.11%-18.26%----
FCF Yield
4.01%3.23%----
Payout Ratio
-0.00%141.66%125.42%45.84%23.78%
Buyback Yield / Dilution
-3.78%-3.69%0.00%0.00%0.00%-
Total Shareholder Return
-3.78%-3.69%0.00%0.00%0.00%-
Updated Apr 28, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q